并且，机会性人类病原体白念珠菌的基因影响棘白菌素类药物的敏感性。
and Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility.
机构信息
Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA.
Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
出版信息
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02299-17. Print 2018 Apr.
Abstract
, a prevailing opportunistic fungal pathogen of humans, has a diploid genome containing three homologous genes that are evolutionarily conserved. One of these, the essential gene , encodes the catalytic subunit of glucan synthase, which is the target of echinocandin drugs and also serves as a site of drug resistance. The other two glucan synthase-encoding genes, and , are also expressed, but their roles in resistance are considered unimportant. However, we report here that expression of is upregulated in strains lacking either or Furthermore, in contrast to what is observed in heterozygous deletion strains, cells lacking or contain increased amounts of cell wall glucan, are more resistant to echinocandin drugs, and consistently are tolerant to cell wall-damaging agents. Our data indicate that and can act as negative regulators of , thereby influencing echinocandin susceptibility.
摘要
白念珠菌是一种流行的人类机会性真菌病原体，具有包含三个同源基因的二倍体基因组，这些基因在进化上是保守的。其中之一，必需基因 ，编码葡聚糖合酶的催化亚基，该酶是棘白菌素类药物的靶标，也是耐药性的部位。另外两个葡聚糖合酶编码基因 和 也被表达，但它们在耐药性中的作用被认为不重要。然而，我们在这里报告，在缺乏 或 的菌株中， 的表达上调。此外，与在杂合 缺失菌株中观察到的情况相反，缺乏 或 的细胞含有更多的细胞壁葡聚糖，对棘白菌素类药物的耐药性增加，并且一致耐受细胞壁破坏剂。我们的数据表明， 和 可以作为 的负调节剂，从而影响棘白菌素类药物的敏感性。
相似文献
1
and Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility.并且，机会性人类病原体白念珠菌的基因影响棘白菌素类药物的敏感性。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02299-17. Print 2018 Apr.
2
Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.Fks1 和 Fks2 在 Candida glabrata 中具有功能冗余性，但受到差异调节：对棘白菌素类耐药性的影响。
Antimicrob Agents Chemother. 2012 Dec;56(12):6304-9. doi: 10.1128/AAC.00813-12. Epub 2012 Oct 1.
3
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响：对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
4
Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.临床显著的白色念珠菌中 micafungin 耐药性涉及葡聚糖合酶催化亚基 GSC1 (FKS1) 等位基因的修饰，随后是杂合性丢失。
J Antimicrob Chemother. 2010 May;65(5):842-52. doi: 10.1093/jac/dkq073. Epub 2010 Mar 16.
5
Novel and modifications in a high-level echinocandin resistant clinical isolate of .棘白菌素类高水平耐药临床分离株的新型和修饰。
Emerg Microbes Infect. 2019;8(1):1619-1625. doi: 10.1080/22221751.2019.1684209.
6
Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.在光滑念珠菌临床分离株中检测到的高水平米卡芬净耐药性的重建，确定了葡聚糖合酶基因表达中的功能性纯合性。
J Antimicrob Chemother. 2012 Jul;67(7):1666-76. doi: 10.1093/jac/dks112. Epub 2012 Apr 18.
7
Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.白色念珠菌中FKS突变的位置和数量选择性地影响体外和体内对棘白菌素治疗的敏感性。
Antimicrob Agents Chemother. 2014 Jul;58(7):3626-35. doi: 10.1128/AAC.00123-14. Epub 2014 Apr 14.
8
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.棘白菌素耐药相关的白念珠菌 FKS1 热点突变的适应性和毒力代价。
J Infect Dis. 2011 Aug 15;204(4):626-35. doi: 10.1093/infdis/jir351.
9
Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.氟康唑敏感性关键区突变和细胞壁几丁质增加导致白念珠菌血流分离株对卡泊芬净短暂暴露后出现棘白菌素类耐药
J Med Microbiol. 2012 Sep;61(Pt 9):1330-1334. doi: 10.1099/jmm.0.045047-0. Epub 2012 May 31.
10
Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the Mutants.棘白菌素类药物联合尼可霉素 Z 对侵袭性白念珠菌血流分离株及其突变株的作用。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.00619-17. Print 2017 Nov.
引用本文的文献
1
Aloin remodels the cell wall of Candida albicans to reduce its hyphal virulence against oral candidiasis.芦荟素重塑白色念珠菌的细胞壁，以降低其对口腔念珠菌病的菌丝毒力。
Appl Microbiol Biotechnol. 2025 Jan 24;109(1):21. doi: 10.1007/s00253-025-13411-7.
2
β-1,6-Glucan plays a central role in the structure and remodeling of the bilaminate fungal cell wall.β-1,6-葡聚糖在真菌双分子层细胞壁的结构和重塑过程中起着核心作用。
Elife. 2024 Dec 5;13:RP100569. doi: 10.7554/eLife.100569.
3
Genes Modulating Echinocandin Susceptibility of Caspofungin-Adapted Mutants Are Constitutively Expressed in Clinical Isolates with Intermediate or Full Resistance to Echinocandins.调节卡泊芬净适应性突变体棘白菌素敏感性的基因在对棘白菌素具有中度或完全抗性的临床分离株中组成性表达。
J Fungi (Basel). 2024 Mar 19;10(3):224. doi: 10.3390/jof10030224.
4
Isobavachalcone exhibits antifungal and antibiofilm effects against by disrupting cell wall/membrane integrity and inducing apoptosis and autophagy.异甘草素通过破坏细胞壁/膜完整性并诱导细胞凋亡和自噬，表现出抗真菌和抗生物膜作用。
Front Cell Infect Microbiol. 2024 Jan 22;14:1336773. doi: 10.3389/fcimb.2024.1336773. eCollection 2024.
5
Antifungal resistance, combinations and pipeline: oh my!抗真菌耐药性、联合用药及研发进展：天哪！
Drugs Context. 2023 Nov 9;12. doi: 10.7573/dic.2023-7-1. eCollection 2023.
6
Antimicrobial Peptides: Avant-Garde Antifungal Agents to Fight against Medically Important Species.抗菌肽：对抗医学上重要真菌物种的先锋抗真菌剂。
Pharmaceutics. 2023 Feb 27;15(3):789. doi: 10.3390/pharmaceutics15030789.
7
Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1.真菌β-1,3-葡聚糖合成酶 FKS1 的结构和机制见解。
Nature. 2023 Apr;616(7955):190-198. doi: 10.1038/s41586-023-05856-5. Epub 2023 Mar 22.
8
Complex and : Biology, Virulence Factors, Immune Response, and Multidrug Resistance.复杂与：生物学、毒力因子、免疫反应及多重耐药性
Infect Drug Resist. 2023 Mar 14;16:1455-1470. doi: 10.2147/IDR.S402754. eCollection 2023.
9
Multiple Genes of Candida albicans Influencing Echinocandin Susceptibility in Caspofungin-Adapted Mutants.白念珠菌多个基因影响棘白菌素适应突变株的敏感性。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0097722. doi: 10.1128/aac.00977-22. Epub 2022 Nov 10.
10
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.主要真菌病原体获得性抗真菌药物耐药性的分子机制及 EUCAST 关于其实验室检测和临床意义的指南。
J Antimicrob Chemother. 2022 Jul 28;77(8):2053-2073. doi: 10.1093/jac/dkac161.
本文引用的文献
1
Candida albicans orf19.3727 encodes phytase activity and is essential for human tissue damage.白色念珠菌的orf19.3727编码植酸酶活性，对人体组织损伤至关重要。
PLoS One. 2017 Dec 7;12(12):e0189219. doi: 10.1371/journal.pone.0189219. eCollection 2017.
2
The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation.白色念珠菌转录因子Cas5将应激反应、耐药性和细胞周期调控联系在一起。
Nat Commun. 2017 Sep 11;8(1):499. doi: 10.1038/s41467-017-00547-y.
3
Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of Genes and Cell Wall Remodeling.白色念珠菌对卡泊芬净的耐受性与至少三种控制基因表达和细胞壁重塑的独特机制有关。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.00071-17. Print 2017 May.
4
Chromosome 5 of Human Pathogen Candida albicans Carries Multiple Genes for Negative Control of Caspofungin and Anidulafungin Susceptibility.人类病原体白色念珠菌的5号染色体携带多个用于负调控卡泊芬净和阿尼芬净敏感性的基因。
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7457-7467. doi: 10.1128/AAC.01888-16. Print 2016 Dec.
5
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy.重症监护病房侵袭性念珠菌病的诊断与管理：应对宿敌的新方法
Crit Care. 2016 May 27;20(1):125. doi: 10.1186/s13054-016-1313-6.
6
Exploiting mitochondria as targets for the development of new antifungals.将线粒体作为新型抗真菌药物开发的靶点
Virulence. 2017 Feb 17;8(2):159-168. doi: 10.1080/21505594.2016.1188235. Epub 2016 May 18.
7
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
8
Genomic profiling of fungal cell wall-interfering compounds: identification of a common gene signature.真菌细胞壁干扰化合物的基因组分析：共同基因特征的鉴定
BMC Genomics. 2015 Sep 5;16(1):683. doi: 10.1186/s12864-015-1879-4.
9
Mechanisms of echinocandin antifungal drug resistance.棘白菌素类抗真菌药物耐药机制。
Ann N Y Acad Sci. 2015 Sep;1354(1):1-11. doi: 10.1111/nyas.12831. Epub 2015 Jul 17.
10
Echinocandin resistance: an emerging clinical problem?棘白菌素耐药性：一个新出现的临床问题？
Curr Opin Infect Dis. 2014 Dec;27(6):484-92. doi: 10.1097/QCO.0000000000000111.
Zotero 插件